Lee Gary K. - Insider Non-Derivative Transactions at Lyell Immunopharma, Inc. (LYEL) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 10, 2025, Lee Gary K.'s relationship to Lyell Immunopharma, Inc. (LYEL) is Officer (Chief Scientific Officer), and currently has 15,366 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other LYEL insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Lee Gary K. - Insider Non-Derivative Transactions of LYEL Common Stock

Lee Gary K. - Insider Non-Derivative Transactions at LYEL

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 11, 2025	Sell -- (Common Stock)	138	16.16	15366
Aug 22, 2025	Sell -- (Common Stock)	1453	10.54	15504
Aug 21, 2025	Acquisition -- (Common Stock)	8000	0	16957
Aug 13, 2025	Sell -- (Common Stock)	136	10.34	8957
Aug 12, 2025	Sell -- (Common Stock)	131	10.53	9093
Feb 11, 2025	Acquisition -- (Common Stock)	112500	0	176696
Feb 10, 2024	Acquisition -- (Common Stock)	40000	0	52700